You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 102 No. 11, November 1984 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (54)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Vitrectomy and Intravitreal Antiviral Drug Therapy in Acute Retinal Necrosis Syndrome

Report of Two Cases

Gholam A. Peyman, MD; Morton F. Goldberg, MD; Eliane Uninsky, MD; Howard Tessler, MD; José Pulido, MD; Robert Hendricks, PhD

Arch Ophthalmol. 1984;102(11):1618-1621.


Abstract

• Two patients with acute retinal necrosis were treated with vitrectomy, intravitreal infusion of acyclovir, and prophylactic scleral buckling procedures. Both patients have had an uneventful postoperative course and a recovery of visual acuity; follow-up has been at five and 14 months. There has been no sign of toxicity from the intravitreally administered acyclovir by electroretinographic or clinical criteria.



Author Affiliations

From the Department of Ophthalmology, University of Illinois at Chicago, Eye and Ear Infirmary.


Footnotes

Accepted for publication July 26, 1984.

Reprint requests to the University of Illinois at Chicago, Eye and Ear Infirmary, 1855 W Taylor St, Chicago, IL 60612 (Dr Peyman).

This investigation was supported in part by core grant 1P3EY01792 from the National Institutes of Health, Bethesda, Md, and by an unrestricted grant from Research to Prevent Blindness Inc, New York.

Sahag Baghdassarian, MD, Paul Mitchell, MD, and Pete Lagouros, MD, assisted in the care of our second patient.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Variable R1 region in varicella zoster virus in fulminant type of acute retinal necrosis syndrome
Abe et al.
Br J Ophthalmol 2000;84:193-198.
ABSTRACT | FULL TEXT  

Clinicopathologic Correlations in Acute Retinal Necrosis Caused by Herpes Simplex Virus Type 2
Rahhal et al.
Arch Ophthalmol 1996;114:1416-1419.
ABSTRACT  

Acquired Immunodeficiency Syndrome--Associated Herpes Simplex Virus Retinitis: Clinical Description and Use of a Polymerase Chain Reaction--Based Assay as a Diagnostic Tool
Cunningham et al.
Arch Ophthalmol 1996;114:834-840.
ABSTRACT  

Retinal Detachments in Patients With Cytomegalovirus Retinitis
Jabs et al.
Arch Ophthalmol 1991;109:794-799.
ABSTRACT  

Acute Retinal Necrosis Neuropathy: Clinical Profile and Surgical Therapy
Sergott et al.
Arch Ophthalmol 1989;107:692-696.
ABSTRACT  

Intravitreal Toxicity of Hydroxyacyclovir (BW-B759U), a New Antiviral Agent
Pulido et al.
Arch Ophthalmol 1985;103:840-841.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.